πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

RIGEL PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for RIGEL PHARMACEUTICALS β€” grant dates, expiration, and drug cross-links.

Patents
373
Expiring ≀24m
18

Quick answer

RIGEL PHARMACEUTICALS has 373 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 18 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 8

  1. US 10947216

    Amide compounds and method for making and using

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10941135

    Nrf2 activating compounds and uses thereof

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10941134

    AMPK-activating heterocyclic compounds and methods for using the same

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10941140

    IRAK inhibitors and method for making and using

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10889562

    Prodrugs of Nrf2 activating compounds and uses thereof

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10858335

    2,3-Disubstituted pyridine compounds as TGF-Ξ² inhibitors and methods of use

    Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10851093

    Tyrosine kinase inhibitors

    Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10844040

    Nrf2 activating compounds and uses thereof

    Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10828301

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10822337

    TGF-Ξ² inhibitorC

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10815206

    RIP1 inhibitory compounds and methods for making and using the same

    Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10792282

    Protein kinase C inhibitors and uses thereof

    Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10774066

    Prodrugs of NRF2 activating compounds and uses thereof

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10774076

    Benzazole compounds and methods for making and using the compounds

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10759855

    Antigen binding molecules to TIGIT

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10709703

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10710983

    2,4-diamino-pyrimidine compounds and method for making and using the compounds

    Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10696693

    Fused imidazole derivatives as TGF-beta inhibitors

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10682350

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10647697

    Nrf2 activating compounds and uses thereof

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10590121

    Kinase inhibitors and methods for making and using

    Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10577381

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10556881

    Nrf2 activating compounds and uses thereof

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10556891

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10493066

    Fumarate analogs and uses thereof

    Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10479783

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10450280

    Tetrazolones as a carboxylic acid bioisosteres

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10434096

    Tyrosine kinase inhibitors

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10421752

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10414758

    Compounds and method for treating autoimmune diseases

    Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10414753

    Amide compounds and method for making and using

    Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10377742

    AMPK-activating heterocyclic compounds and methods for using the same

    Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10369148

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10370367

    IRAK inhibitors and method for making and using

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10357505

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10314840

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10287295

    TGF-Ξ² inhibitors

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10259826

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10233170

    2,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10208074

    Pyrazole compounds and method for making and using the compounds

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10208075

    Pyrazole compounds and method for making and using the compounds

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10166216

    Substituted triazoles useful as Axl inhibitors

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10130623

    Tyrosine kinase inhibitors

    Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10065946

    Benzazole compounds and methods for making and using the compounds

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10040766

    Ubiquitination inhibitors

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10005777

    Protein kinase C inhibitors and uses thereof

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10005767

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9982000

    Pyrazole compounds and method for making and using the compounds

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does RIGEL PHARMACEUTICALS have?

373 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do RIGEL PHARMACEUTICALS patents expire?

18 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.